48 related articles for article (PubMed ID: 28954272)
1. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.
Xiao G; Wang X; Yu Y
Cell Physiol Biochem; 2017; 43(2):840-851. PubMed ID: 28954272
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma.
Ma LJ; Wu J; Zhou E; Yin J; Xiao XP
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32432318
[TBL] [Abstract][Full Text] [Related]
3. Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.
Aravindan S; Ramraj S; Kandasamy K; Thirugnanasambandan SS; Somasundaram DB; Herman TS; Aravindan N
Oncotarget; 2017 Jan; 8(4):5717-5734. PubMed ID: 27974694
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.
Willenbrock S; Wagner S; Reimann-Berg N; Moulay M; Hewicker-Trautwein M; Nolte I; Murua Escobar H
PLoS One; 2014; 9(6):e98788. PubMed ID: 24914948
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
Franses JW; Philipp J; Missios P; Bhan I; Liu A; Yashaswini C; Tai E; Zhu H; Ligorio M; Nicholson B; Tassoni EM; Desai N; Kulkarni AS; Szabolcs A; Hong TS; Liss AS; Fernandez-Del Castillo C; Ryan DP; Maheswaran S; Haber DA; Daley GQ; Ting DT
Nat Commun; 2020 Jul; 11(1):3303. PubMed ID: 32620742
[TBL] [Abstract][Full Text] [Related]
6. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.
Wang Y; Kumar S; Rachagani S; Sajja BR; Xie Y; Hang Y; Jain M; Li J; Boska MD; Batra SK; Oupický D
Biomaterials; 2016 Sep; 101():108-120. PubMed ID: 27267632
[TBL] [Abstract][Full Text] [Related]
7. Let Us Reason Together.
Int Dent J (Phila); 1893 Jan; 14(1):71-73. PubMed ID: 37911040
[No Abstract] [Full Text] [Related]
8. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.
Carreras-Torres R; Johansson M; Gaborieau V; Haycock PC; Wade KH; Relton CL; Martin RM; Davey Smith G; Brennan P
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954281
[TBL] [Abstract][Full Text] [Related]
9. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation.
Ashrafizadeh M; Zhang W; Tian Y; Sethi G; Zhang X; Qiu A
Cancer Metastasis Rev; 2024 Mar; 43(1):229-260. PubMed ID: 38374496
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.
Moison C; Spinella JF; Chagraoui J; Lavallée VP; Lehnertz B; Thiollier C; Boivin I; Mayotte N; MacRae T; Marinier A; Hébert J; Sauvageau G
Blood Adv; 2022 Aug; 6(16):4793-4806. PubMed ID: 35797243
[TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Significance of High-Mobility Group AT-hook 2 (HMGA2) in Osteosarcoma.
Cui J; Dean D; Hornicek FJ; Yi G; Duan Z
Orthop Surg; 2022 May; 14(5):955-966. PubMed ID: 35388973
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZFAS1 promotes pancreatic cancer proliferation and metastasis by sponging miR-497-5p to regulate HMGA2 expression.
Rao M; Xu S; Zhang Y; Liu Y; Luan W; Zhou J
Cell Death Dis; 2021 Sep; 12(10):859. PubMed ID: 34552050
[TBL] [Abstract][Full Text] [Related]
13. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance.
Patil K; Khan FB; Akhtar S; Ahmad A; Uddin S
Cancer Metastasis Rev; 2021 Sep; 40(3):691-720. PubMed ID: 34453639
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: emerging driver of cancer perineural invasion.
Zhang M; Xian HC; Dai L; Tang YL; Liang XH
Cell Biosci; 2021 Jun; 11(1):117. PubMed ID: 34187567
[TBL] [Abstract][Full Text] [Related]
15. Association of
Zhou J; Wang P; Zhang R; Huang X; Dai H; Yuan L; Ruan J
Pharmgenomics Pers Med; 2021; 14():601-607. PubMed ID: 34079335
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 as a Critical Regulator in Cancer Development.
Mansoori B; Mohammadi A; Ditzel HJ; Duijf PHG; Khaze V; Gjerstorff MF; Baradaran B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33668453
[TBL] [Abstract][Full Text] [Related]
17. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.
Ye J; Qi L; Du Z; Yu L; Chen K; Li R; Feng R; Zhai W
Aging (Albany NY); 2021 Feb; 13(4):5607-5620. PubMed ID: 33591948
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-Mediated Subpathway Identification and Network Module Analysis to Reveal Prognostic Markers in Human Pancreatic Cancer.
Liu Y; Cui Y; Bai X; Feng C; Li M; Han X; Ai B; Zhang J; Li X; Han J; Zhu J; Jiang Y; Pan Q; Wang F; Xu M; Li C; Wang Q
Front Genet; 2020; 11():606940. PubMed ID: 33362865
[TBL] [Abstract][Full Text] [Related]
19. The pro-migration and anti-apoptosis effects of HMGA2 in HUVECs stimulated by hypoxia.
Cai ZL; Liu C; Yao Q; Xie QW; Hu TT; Wu QQ; Tang QZ
Cell Cycle; 2020 Dec; 19(24):3534-3545. PubMed ID: 33315504
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miR-21/Let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases.
Yang G; Wang T; Qu X; Chen S; Han Z; Chen S; Chen M; Lin J; Yu S; Gao L; Peng K; Kang M
Asia Pac J Clin Oncol; 2020 Aug; 16(4):280-286. PubMed ID: 32525285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
